基本信息
浏览量:245
职业迁徙
个人简介
Yasuhiro Kodera currently works as a chairman of the Department of Gastroenterological Surgery, Nagoya University Graduate School of Medicine. Alongside his continuing job as a consultant for gastric surgery and multimodality treatment, he is in charge of clinical and research works at a department where main disease of interest are cancers of the esophagus, stomach, colon/rectum, pancreas, and liver, and inflammatory bowel disease.
His main interest includes diagnosis and treatment of peritoneal metastasis from gastric cancer. He has spent several years running multi-institutional clinical trials for intraperitoneal chemotherapy using paclitaxel. A small-scale randomized phase II trial looking at IP administration of paclitaxel as a single agent ended in a failure (Takahashi N, et al. Gastric Cancer, Epub ahead of print, 2018), but a randomized phase III trial that explored its combination with systemic chemotherapy (Principal Investigator: Prof. Ishigami) produced several promising results (J Clin Oncol, in press). He served as a principal investigator in another successful phase III adjuvant trial exploring S-1/docetaxel in Stage III gastric cancer and plans to present the results at ASCO 2018. Currently a chair of the board of directors at Japan Gastric Cancer Association and board of director at Japan Surgical Society and Japanese Society of Clinical Oncology, he serves as an associate editor of Gastric Cancer and editorial board member of the World Journal of Surgery, European Journal of Surgical Oncology, and Annals of Gastroenterological Surgery.
As of 2016, he serves as a vice-director of the Nagoya University Hospital.
His main interest includes diagnosis and treatment of peritoneal metastasis from gastric cancer. He has spent several years running multi-institutional clinical trials for intraperitoneal chemotherapy using paclitaxel. A small-scale randomized phase II trial looking at IP administration of paclitaxel as a single agent ended in a failure (Takahashi N, et al. Gastric Cancer, Epub ahead of print, 2018), but a randomized phase III trial that explored its combination with systemic chemotherapy (Principal Investigator: Prof. Ishigami) produced several promising results (J Clin Oncol, in press). He served as a principal investigator in another successful phase III adjuvant trial exploring S-1/docetaxel in Stage III gastric cancer and plans to present the results at ASCO 2018. Currently a chair of the board of directors at Japan Gastric Cancer Association and board of director at Japan Surgical Society and Japanese Society of Clinical Oncology, he serves as an associate editor of Gastric Cancer and editorial board member of the World Journal of Surgery, European Journal of Surgical Oncology, and Annals of Gastroenterological Surgery.
As of 2016, he serves as a vice-director of the Nagoya University Hospital.
研究兴趣
论文共 299 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
INTERNATIONAL JOURNAL OF CANCERno. 7 (2024): 1272-1284
SURGERY TODAYno. 1 (2024): 41-52
APPLIED PHYSICS LETTERSno. 10 (2024)
Gastric Cancerpp.1-25, (2024)
GASTRIC CANCERno. 1 (2024): 1-2
Annals of surgical oncologyno. 5 (2024): 3473-3474
Annals of Gastroenterological Surgery (2024)
CANCER MEDICINEno. 24 (2023): 22185-22195
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn